AstraZeneca (AZN - Get Report) is trending as the drugmaker announced it will cut an additional 2,300 jobs. The company said the cuts will take place among its sales representatives. They come on top of 1,600 jobs the company announced it would eliminate in research and development on March 18. AstraZeneca said it expects to incur $2.3 billion in one-time restructuring charges. It anticipates $800 million in cost savings per year after 2016. The company also plans to narrow its drug research focus, concentrating on respiratory, inflammation and autoimmune diseases, cardiovascular and metabolic illnesses and cancer.
Lufthansa is another popular search. The airline canceled nearly 40% of its flights on Thursday as its staff went on strike.